Enhanced smokable therapeutic cannabis product and method for making same

Abstract

An enhanced smokable cannabis-based product produced by separating hash resin from plant material of the cannabis plant, pressing the hash resin to expel oil, leaving spent hash resin, extracting further cannabinoids from the spent hash resin using MCT oil, enriching the extracted oil with a formulation comprising at least purified-myrcene, and spraying the enriched oil onto dried smokable cannabis plant matter.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims benefit of, and priority to, U.S. provisional patent application 62 / 638,232 titled “ENHANCED SMOKABLE THERAPEUTIC CANNABIS PRODUCT AND METHOD FOR MAKING SAME”, filed on Mar. 4, 2018, and is also a continuation-in-part of U.S. patent application Ser. No. 15 / 616,802, titled “DEVICE FOR DELIVERY OF SMOKABLE CANNABIS AND MANUFACTURING METHOD FOR SAME”, filed on Jun. 7, 2017, and is also a continuation-in-part of U.S. patent application Ser. No. 15 / 615,829, titled “SYSTEM AND METHOD ENHANCED CANNABINIOD EFFECT DELIVERY”, filed on Jun. 6, 2017, the entire specifications of each of which are incorporated herein by reference.BACKGROUND OF THE INVENTIONField of the Invention[0002]The present invention is in the field of therapeutic uses of the cannabis plant, and more specifically the field of therapeutic smokable products derived from cannabis. Discussion of the State of the Art[0003]Recently, multiple states have passed l...

AI Technical Summary

Benefits of technology

[0005]Accordingly, the inventor has conceived and reduced to practice, in a preferred aspect, an enhanced smokable therapeutic cannabis product and method for making same. The cannabinoid, terpene, and flavonoid formulations used in enhanced smokable cannabis products according to aspects of the invention are intended to mitigate at least one medical issue. For example, the terpene myrcene increases the permeability of the blood-brain-barrier to other terpenes, cannabinoids, and flavonoids which raises the saturation level of at least one cannabinoid receptor, such as CB1, within the human body. In another example, medium chain triglyceride (MCT) oil is mixed with cannabis-derived oils using a formulation of the invention, and the combined oil sprayed on cannabis plant matter. Advantageously, such oil-sprayed plant matter, when smoked, has improved taste and gives a more even burn, while also providing more of a desired therapeutic effect. In an aspect, dried cannabis plant matter prepared in this way may be wrapped into a conical smokable product.

[0006]The inventors have discovered, in particular, that using the methods described herein rather than, as is commonly done in the art, infusing smokable plant material directly with hash resin, provides a superior product that tastes better, smokes more smoothly, and has predictable therapeutic effects (which may in fact be varied, according to aspects of the invention, by varying the cannabinoid profile of the oil used to spray plant matter as described herein).

[0007]According to a preferred aspect, an enhanced smokable cannabis-based product is produced by separating hash resin from plant material of the cannabis plant, pressing the hash resin to expel oil, leaving spent hash resin, extracting further cannabinoids from the spent hash resin using MCT oil, enriching the extracted oil with a formulation comprising at least purified-myrcene, and spraying the enriched oil onto dried smokable cannabis plant matter.

Problems solved by technology

Unfortunately, smokable cannabis products are difficult to use for therapeutic purposes, as their chemical content varies widely based on the plant strains and plant parts used.

Additionally, smokable cannabis products often present a harsh affect and poor taste.

Images